Screener
Lexaria Bioscience LEXX Q1 2026 earnings
Reported April 13, 2026 · Before market open
Revenue$20.0KMiss by $30.0K
EPS-$0.06Beat by $0.04
Revenue estimate$50.0K
EPS estimate-$0.10
Next report
Oct 28, 2026 (in 2 months)Revenue estimate$50.0K
EPS estimate-$0.90
Versus estimates
Revenue
Q1 2026$20.0KMiss by $30.0K
Q3 2025$174.0KBeat by $37.0KQ2 2025$174.0KBeat by $37.0KQ1 2025$174.0KBeat by $82.7KDiluted EPS
FAQ
- When did Lexaria Bioscience report Q1 2026 earnings?
- Lexaria Bioscience (LEXX) reported Q1 2026 earnings on April 13, 2026 before market open.
- What were Lexaria Bioscience's Q1 2026 revenue and EPS?
- Lexaria Bioscience reported revenue of $20.0K and eps of $-0.06 for Q1 2026.
- Did Lexaria Bioscience beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $50.0K by $30.0K. EPS beat the consensus estimate of $-0.10 by $0.04.
- How did Lexaria Bioscience's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 88.5% from $174.0K a year earlier and eps grew 60.0% from $-0.15.
- Where can I find Lexaria Bioscience's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001640334-26-000687) directly on SEC EDGAR. The filing index links above go to sec.gov.
